116 related articles for article (PubMed ID: 3498950)
1. Clonogenic and functional potential of T lymphocytes infiltrating human solid tumors.
von Fliedner V; Qiao L; Whiteside TL; Leyvraz S; Barras C; Miescher S
Prog Clin Biol Res; 1987; 244():223-32. PubMed ID: 3498950
[No Abstract] [Full Text] [Related]
2. Tumor-infiltrating lymphocytes from human solid tumors: antigen-specific killer T lymphocytes of activated natural killer lymphocytes.
Whiteside TL; Heo DS; Takagi S; Herberman RB
Immunol Ser; 1989; 48():139-57. PubMed ID: 2488318
[No Abstract] [Full Text] [Related]
3. Tumor-infiltrating lymphocytes: evidence for specific immune reactions against growing cancers in mice and humans.
Topalian SL; Rosenberg SA
Important Adv Oncol; 1990; ():19-41. PubMed ID: 2182519
[No Abstract] [Full Text] [Related]
4. Cultures of human natural killer cells (large granular lymphocytes) and T cells in the presence of interleukin-2-containing conditioned medium.
Timonen T; Ortaldo JR; Vose BM; Henkart M; Alvarez J; Herberman RB
J Reticuloendothel Soc; 1983 Jan; 33(1):67-80. PubMed ID: 6601190
[No Abstract] [Full Text] [Related]
5. The use of T cell lines as probes for studies of cytotoxic anti-tumor response and its regulation in the human system.
Mukherji B; Tatake RJ; Guha A; Nashed A; Ergin MT
Prog Clin Biol Res; 1987; 244():251-8. PubMed ID: 2958871
[No Abstract] [Full Text] [Related]
6. Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression.
López-Botet M; Silva A; Rodríguez J; de Landazuri MO
J Immunol; 1982 Sep; 129(3):1109-15. PubMed ID: 6213707
[No Abstract] [Full Text] [Related]
7. Long-term cultures of immunocompetent T lymphocytes.
Bonnard GD
Prog Clin Biol Res; 1981; 58():45-56. PubMed ID: 6455669
[No Abstract] [Full Text] [Related]
8. Functional characterization of human thymocytes: a limiting dilution analysis of precursors with proliferative and cytolytic activities.
Lopez-Botet M; Moretta L
J Immunol; 1985 Apr; 134(4):2299-304. PubMed ID: 3919089
[TBL] [Abstract][Full Text] [Related]
9. Activation through CD3 molecule leads to clonal expansion of all human peripheral blood T lymphocytes: functional analysis of clonally expanded cells.
Weber WE; Buurman WA; Vandermeeren MM; Raus JC
J Immunol; 1985 Oct; 135(4):2337-42. PubMed ID: 3875651
[TBL] [Abstract][Full Text] [Related]
10. [Human interleukin 2].
Chouaib S; Fradelizi D
Ann Immunol (Paris); 1983; 134D(2):157-65. PubMed ID: 6419669
[No Abstract] [Full Text] [Related]
11. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells.
Uchiyama T; Nelson DL; Fleisher TA; Waldmann TA
J Immunol; 1981 Apr; 126(4):1398-403. PubMed ID: 6451645
[No Abstract] [Full Text] [Related]
12. A human large granular lymphocyte clone with natural killer-like activity and T cell-like surface markers.
Sheehy MJ; Quintieri FB; Leung DY; Geha RS; Dubey DP; Limmer CE; Yunis EJ
J Immunol; 1983 Feb; 130(2):524-6. PubMed ID: 6600239
[No Abstract] [Full Text] [Related]
13. Long-term culture, cloning, and surface markers of mixed leukocyte culture-derived human T lymphocytes with natural killer-like cytotoxicity.
Pawelec GP; Hadam MR; Ziegler A; Lohmeyer J; Rehbein A; Kumbier I; Wernet P
J Immunol; 1982 Apr; 128(4):1892-6. PubMed ID: 6460813
[No Abstract] [Full Text] [Related]
14. Human T-cell growth factor (TCGF).
Sarin PS; Gallo RC
Crit Rev Immunol; 1984; 4(4):279-305. PubMed ID: 6232114
[No Abstract] [Full Text] [Related]
15. Activation of lymphocyte anti-tumor responses in man. Towards an understanding of effector cell heterogeneity?
Vose BM
Cancer Immunol Immunother; 1984; 17(2):73-5. PubMed ID: 6235911
[No Abstract] [Full Text] [Related]
16. Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.
Flomenberg N; Welte K; Mertelsmann R; O'Reilly R; Dupont B
J Immunol; 1983 Jun; 130(6):2635-43. PubMed ID: 6222110
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 reconstitutes natural killer activity in transplant recipients.
Citterio F; Cauda R; Pozzetto U; Tumbarello M; Serino F; Ortona L; Castagneto M
Transplant Proc; 1989 Feb; 21(1 Pt 1):80-1. PubMed ID: 2784904
[No Abstract] [Full Text] [Related]
18. Cord IgM antibody specific for human killer T cells: T lymphocytotoxic human fetal antibody (TLFA) recognizing maternal killer T cells proliferating in the presence of interleukin 2.
Miyagawa Y; Komiyama A; Akabane T; Uehara Y; Yano A
J Immunol; 1982 Nov; 129(5):1993-6. PubMed ID: 6981670
[TBL] [Abstract][Full Text] [Related]
19. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
Giaccone G; Punt CJ; Ando Y; Ruijter R; Nishi N; Peters M; von Blomberg BM; Scheper RJ; van der Vliet HJ; van den Eertwegh AJ; Roelvink M; Beijnen J; Zwierzina H; Pinedo HM
Clin Cancer Res; 2002 Dec; 8(12):3702-9. PubMed ID: 12473579
[TBL] [Abstract][Full Text] [Related]
20. [Effects of prostaglandins on the activity of natural killer cells during tumor growth].
Shparyk IaV; Bilynskiĭ BT; Iuk TL
Eksp Onkol; 1990; 12(3):10-4. PubMed ID: 2188828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
